Predict your next investment

Babyscripts company logo
Corporation
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Healthcare
getbabyscripts.com

See what CB Insights has to offer

Total Raised

$31.3M

Investors Count

24

Deal Terms

1

Babyscripts Funding, Babyscripts Valuation & Babyscripts Revenue

10 Fundings

Babyscripts's latest funding round was a Series B - IV for $12M on September 10, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/10/2021

Series B - IV

$12M

$0.00B

((9.99x))

FY 1234

4

12/8/2020

Unattributed VC

$4M

$0.00B

((9.99x))

FY 1234

2

3/19/2019

Series B - III

$0.5M

$0.00B

((9.99x))

FY 1234

2

1/7/2019

Series B - II

$99M

$0.00B

((9.99x))

FY 1234

10

6/30/2017

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

Date

9/10/2021

12/8/2020

3/19/2019

1/7/2019

6/30/2017

Round

Series B - IV

Unattributed VC

Series B - III

Series B - II

Series B

Amount

$12M

$4M

$0.5M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

4

2

2

10

10

Babyscripts Deal Terms

1 Deal Term

Babyscripts's deal structure is available for 1 funding round, including their Series B from June 30, 2017.

Round

Series B

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

Babyscripts Investors

24 Investors

Babyscripts has 24 investors. WellSpan Health invested in Babyscripts's Series B - IV funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/8/2020

9/10/2021

3
Other Investors, Unattributed VC (2020), Series B - IV (2021)

Non-Profit Foundation

Pennsylvania

12/8/2020

9/10/2021

2
Unattributed VC, Series B - IV (2021)

Corporation

Wisconsin

12/8/2020

9/10/2021

2
Unattributed VC, Series B - IV (2021)

Corporate Venture

Colorado

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporation

Arizona

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Spain

First funding

12/8/2020

12/8/2020

12/8/2020

00/00/0000

00/00/0000

Last Funding

9/10/2021

9/10/2021

9/10/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

3
Other Investors, Unattributed VC (2020), Series B - IV (2021)
2
Unattributed VC, Series B - IV (2021)
2
Unattributed VC, Series B - IV (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Non-Profit Foundation

Corporation

Corporate Venture

Corporation

Venture Capital

Location

Pennsylvania

Wisconsin

Colorado

Arizona

Spain

Babyscripts Acquisitions

1 Acquisition

Babyscripts acquired 1 company. Their latest acquisition was iBirth on June 25, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/25/2018

Acquired

1

Date

6/25/2018

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.